234 related articles for article (PubMed ID: 23948549)
21. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma.
Laberiano-Fernandez C; Gan Q; Wang SM; Tamegnon A; Wistuba I; Yoon E; Roy-Chowdhuri S; Parra ER
J Am Soc Cytopathol; 2024; 13(3):161-173. PubMed ID: 38519275
[TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusions.
Thickett DR; Armstrong L; Millar AB
Thorax; 1999 Aug; 54(8):707-10. PubMed ID: 10413724
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal Measurement of Pleural Fluid Biochemistry and Cytokines in Malignant Pleural Effusions.
Thomas R; Cheah HM; Creaney J; Turlach BA; Lee YC
Chest; 2016 Jun; 149(6):1494-500. PubMed ID: 26836920
[TBL] [Abstract][Full Text] [Related]
24. VEGF-D as a marker in the aid of malignant metastatic pleural effusion diagnosis.
Maa HC; Chao TT; Wang CY; Pei D; Liang YJ; Chen YL
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):209-14. PubMed ID: 25221955
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters.
Bayram N; Karakan Y; Uyar M; Ozyurt B; Filiz A
Niger J Clin Pract; 2018 Jan; 21(1):59-62. PubMed ID: 29411725
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions--preliminary results].
Jankowska R; Porebska I; Dyła T
Pneumonol Alergol Pol; 2002; 70(5-6):258-64. PubMed ID: 12518624
[TBL] [Abstract][Full Text] [Related]
27. Platelet factor 4 regulates T cell effector functions in malignant pleural effusions.
Mulet M; Zamora C; Porcel JM; Nieto JC; Pajares V; Muñoz-Fernandez AM; Calvo N; Esquerda A; Vidal S
Cancer Lett; 2020 Oct; 491():78-86. PubMed ID: 32726613
[TBL] [Abstract][Full Text] [Related]
28. Tumor necrosis factor-alpha promotes malignant pleural effusion.
Stathopoulos GT; Kollintza A; Moschos C; Psallidas I; Sherrill TP; Pitsinos EN; Vassiliou S; Karatza M; Papiris SA; Graf D; Orphanidou D; Light RW; Roussos C; Blackwell TS; Kalomenidis I
Cancer Res; 2007 Oct; 67(20):9825-34. PubMed ID: 17942913
[TBL] [Abstract][Full Text] [Related]
29. HMGB1 Promotes Myeloid Egress and Limits Lymphatic Clearance of Malignant Pleural Effusions.
Soloff AC; Jones KE; Powers AA; Murthy P; Wang Y; Russell KL; Byrne-Steele M; Lund AW; Yuan JM; Monaco SE; Han J; Dhupar R; Lotze MT
Front Immunol; 2020; 11():2027. PubMed ID: 33013860
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.
Bunjhoo H; Wang ZY; Chen HL; Cheng S; Xiong WN; Xu YJ; Cao Y
Asian Pac J Cancer Prev; 2012; 13(7):3495-9. PubMed ID: 22994784
[TBL] [Abstract][Full Text] [Related]
31. VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes.
Hooper CE; Elvers KT; Welsh GI; Millar AB; Maskell NA
Lung Cancer; 2012 Aug; 77(2):443-9. PubMed ID: 22487430
[TBL] [Abstract][Full Text] [Related]
32. Th1 and Th2 cytokine profiles in malignant pleural effusion.
Ghayumi MA; Mojtahedi Z; Fattahi MJ
Iran J Immunol; 2011 Dec; 8(4):195-200. PubMed ID: 22201616
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor in malignant pleural effusion associated with lung cancer.
Yanagawa H; Takeuchi E; Suzuki Y; Ohmoto Y; Bando H; Sone S
Cancer Immunol Immunother; 1999 Oct; 48(7):396-400. PubMed ID: 10501853
[TBL] [Abstract][Full Text] [Related]
35. Transcription expression and clinical significance of vascular endothelial growth factor mRNA and endostatin mRNA in pleural effusions of patients with lung cancer.
Chen Y; Liang B; Zhao YJ; Wang SC; Fan YB; Wu GP
Diagn Cytopathol; 2012 Apr; 40(4):287-91. PubMed ID: 22431315
[TBL] [Abstract][Full Text] [Related]
36. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions.
Zhou WB; Bai M; Jin Y
Int J Tuberc Lung Dis; 2009 Mar; 13(3):381-6. PubMed ID: 19275801
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study.
Shojaee S; Voelkel N; Farkas L; de Wit M; Lee HJ
J Bronchology Interv Pulmonol; 2013 Oct; 20(4):304-8. PubMed ID: 24162112
[TBL] [Abstract][Full Text] [Related]
39. Pleural cancer antigen-125 levels in benign and malignant pleural effusions.
Choi WI; Qama D; Lee MY; Kwon KY
Int J Tuberc Lung Dis; 2013 May; 17(5):693-7. PubMed ID: 23575338
[TBL] [Abstract][Full Text] [Related]
40. Metabonomic classification and detection of small molecule biomarkers of malignant pleural effusions.
Zhou XM; He CC; Liu YM; Zhao Y; Zhao D; Du Y; Zheng WY; Li JX
Anal Bioanal Chem; 2012 Dec; 404(10):3123-33. PubMed ID: 23052876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
